1. Home
  2. COOK vs LENZ Comparison

COOK vs LENZ Comparison

Compare COOK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

N/A

Current Price

$63.97

Market Cap

170.4M

ML Signal

N/A

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$5.46

Market Cap

155.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
LENZ
Founded
1985
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.4M
155.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
COOK
LENZ
Price
$63.97
$5.46
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$53.00
$44.00
AVG Volume (30 Days)
66.8K
865.5K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$559,520,000.00
$19,088,000.00
Revenue This Year
N/A
$50.42
Revenue Next Year
$3.07
$197.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$4.68
52 Week High
$86.59
$50.19

Technical Indicators

Market Signals
Indicator
COOK
LENZ
Relative Strength Index (RSI) 46.69 54.71
Support Level $58.44 $4.94
Resistance Level $76.22 $6.18
Average True Range (ATR) 4.99 0.42
MACD -0.14 0.07
Stochastic Oscillator 59.66 47.25

Price Performance

Historical Comparison
COOK
LENZ

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: